Lv31
280 积分 2023-12-02 加入
Personalized Prediction of Postoperative Complication and Survival Among Colorectal Liver Metastases Patients Receiving Simultaneous Resection Using Machine Learning Approaches: A Multi-center Study
4小时前
待确认
FRI-397 A machine learning model to predict liver-related outcomes after the functional cure of chronic hepatitis B
4小时前
已完结
Factors associated with reaching maintenance therapy in patients with advanced biliary tract cancer treated with durvalumab: Real‐world results from a multicenter and multinational study
7天前
已完结
Age-Dependent Female Survival Advantage in Hepatocellular Carcinoma: A Multicenter Cohort Study
8天前
已完结
Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study
8天前
已完结
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trial
1个月前
已完结
Survival benefit of adequate lymphadenectomy in patients undergoing liver resection for clinically node-negative intrahepatic cholangiocarcinoma
1个月前
已完结
Tumour burden predicts outcomes after curative resection of multifocal intrahepatic cholangiocarcinoma
1个月前
已完结
Durvalumab plus chemotherapy in advanced biliary tract cancer: 3-year overall survival update from the phase III TOPAZ-1 study
1个月前
已完结
Integrating cytotoxic, targeted and immune therapies for cholangiocarcinoma
1个月前
已完结
皖公网安备34019202002308
